These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8604507)

  • 1. Risk factors for Trypanosoma cruzi infection in California blood donors.
    Galel SA; Kirchhoff LV
    Transfusion; 1996 Mar; 36(3):227-31. PubMed ID: 8604507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a questionnaire to identify potential blood donors at risk for infection with Trypanosoma cruzi.
    Appleman MD; Shulman IA; Saxena S; Kirchhoff LV
    Transfusion; 1993 Jan; 33(1):61-4. PubMed ID: 8424268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for prevention of transfusion-associated Chagas' disease.
    Moraes-Souza H; Bordin JO
    Transfus Med Rev; 1996 Jul; 10(3):161-70. PubMed ID: 8809967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific antibodies to Trypanosoma cruzi among blood donors in Los Angeles, California.
    Shulman IA; Appleman MD; Saxena S; Hiti AL; Kirchhoff LV
    Transfusion; 1997 Jul; 37(7):727-31. PubMed ID: 9225937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of antibodies to Trypanosoma cruzi among solid organ donors in Southern California: a population at risk.
    Nowicki MJ; Chinchilla C; Corado L; Matsuoka L; Selby R; Steurer F; Mone T; Mendez R; Aswad S
    Transplantation; 2006 Feb; 81(3):477-9. PubMed ID: 16477238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission.
    Leiby DA; Herron RM; Read EJ; Lenes BA; Stumpf RJ
    Transfusion; 2002 May; 42(5):549-55. PubMed ID: 12084162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of antibody to Trypanosoma cruzi among blood donors in Los Angeles, California.
    Kerndt PR; Waskin HA; Kirchhoff LV; Steurer F; Waterman SH; Nelson JM; Gellert GA; Shulman IA
    Transfusion; 1991; 31(9):814-8. PubMed ID: 1755086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors.
    Cantey PT; Stramer SL; Townsend RL; Kamel H; Ofafa K; Todd CW; Currier M; Hand S; Varnado W; Dotson E; Hall C; Jett PL; Montgomery SP
    Transfusion; 2012 Sep; 52(9):1922-30. PubMed ID: 22404755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Trypanosoma cruzi antibodies in blood donors from Veracruz State, Mexico.
    Hernández-Romano P; Cámara-Contreras M; Bravo-Sarmiento E; López-Balderas N
    Transfusion; 2015 Mar; 55(3):647-56. PubMed ID: 25208459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of transfusional Trypanosoma cruzi infection in Latin America.
    Schmunis GA
    Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():93-101. PubMed ID: 10677696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of Trypanosoma cruzi infection among at-risk blood donors in Japan.
    Sayama Y; Furui Y; Takakura A; Ishinoda M; Matsumoto C; Taira R; Igarashi S; Momose S; Matsubayashi K; Uchida S; Hino S; Nagai T; Satake M
    Transfusion; 2019 Jan; 59(1):287-294. PubMed ID: 30474861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chagas disease and blood transfusion: an emerging issue in non-endemic countries].
    Assal A; Corbi C
    Transfus Clin Biol; 2011 Apr; 18(2):286-91. PubMed ID: 21440479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human and sylvatic Trypanosoma cruzi infection in California.
    Navin TR; Roberto RR; Juranek DD; Limpakarnjanarat K; Mortenson EW; Clover JR; Yescott RE; Taclindo C; Steurer F; Allain D
    Am J Public Health; 1985 Apr; 75(4):366-9. PubMed ID: 3919598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi.
    Custer B; Agapova M; Bruhn R; Cusick R; Kamel H; Tomasulo P; Biswas H; Tobler L; Lee TH; Caglioti S; Busch M
    Transfusion; 2012 Sep; 52(9):1901-11. PubMed ID: 22339233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of meaningful levels of Trypanosoma cruzi in platelet concentrates from seropositive blood donors.
    Cancino-Faure B; Fisa R; Riera C; Bula I; Girona-Llobera E; Jimenez-Marco T
    Transfusion; 2015 Jun; 55(6):1249-55. PubMed ID: 25683267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European strategies against the parasite transfusion risk.
    Reesink HW
    Transfus Clin Biol; 2005 Feb; 12(1):1-4. PubMed ID: 15814284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain).
    Piron M; Vergés M; Muñoz J; Casamitjana N; Sanz S; Maymó RM; Hernández JM; Puig L; Portús M; Gascón J; Sauleda S
    Transfusion; 2008 Sep; 48(9):1862-8. PubMed ID: 18522707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deferral of blood donors who have ever stayed in a Trypanosoma cruzi endemic area: An international survey.
    Lewin A; Tonnetti L; Renaud C; Drews SJ; Bloch EM; O'Brien SF;
    Vox Sang; 2024 Sep; 119(9):921-926. PubMed ID: 38872389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donors.
    Leiby DA; Read EJ; Lenes BA; Yund AJ; Stumpf RJ; Kirchhoff LV; Dodd RY
    J Infect Dis; 1997 Oct; 176(4):1047-52. PubMed ID: 9333165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The early implementation of Trypanosoma cruzi antibody screening of donors and donations within England: preempting a problem.
    Kitchen AD; Hewitt PE; Chiodini PL
    Transfusion; 2012 Sep; 52(9):1931-9. PubMed ID: 22414025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.